Product NDC: | 57520-0431 |
Proprietary Name: | Type 11 Dizziness Regular |
Non Proprietary Name: | Belladonna, Phosphorus, Pulsatilla, Calcarea carbonica, Silicea, |
Active Ingredient(s): | 6; 12; 6; 6; 12 [hp_X]/mg; [hp_X]/mg; [hp_X]/mg; [hp_X]/mg; [hp_X]/mg & nbsp; Belladonna, Phosphorus, Pulsatilla, Calcarea carbonica, Silicea, |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 57520-0431 |
Labeler Name: | Apotheca Company |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED HOMEOPATHIC |
Start Marketing Date: | 20100715 |
Package NDC: | 57520-0431-1 |
Package Description: | 15000 mg in 1 BOTTLE (57520-0431-1) |
NDC Code | 57520-0431-1 |
Proprietary Name | Type 11 Dizziness Regular |
Package Description | 15000 mg in 1 BOTTLE (57520-0431-1) |
Product NDC | 57520-0431 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Belladonna, Phosphorus, Pulsatilla, Calcarea carbonica, Silicea, |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20100715 |
Marketing Category Name | UNAPPROVED HOMEOPATHIC |
Labeler Name | Apotheca Company |
Substance Name | ATROPA BELLADONNA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PULSATILLA VULGARIS; SILICON DIOXIDE |
Strength Number | 6; 12; 6; 6; 12 |
Strength Unit | [hp_X]/mg; [hp_X]/mg; [hp_X]/mg; [hp_X]/mg; [hp_X]/mg |
Pharmaceutical Classes |